Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
G.JiaL.GuoL
the limited human pharmacokinetic data reported by Teichman and colleagues (2006) were for the DAC form
STEP 1 and STEP-UP enrolled adults living with obesity, with slightly lower starting BMIs and different inclusion criteria
Retatrutides Potential Benefits for PCOS The medications effects on insulin sensitivity may provide particular benefit for PCOS patients
Another EASD annual meeting presentation showed that tirzepatide was better than semaglutide for controlling blood sugar and weight loss
RetatrutideMounjaro (Tirzepatide)Wegovy (Semaglutide) Mechanism Triple (GLP-1 + GIP + Glucagon)Dual (GLP-1 + GIP)Single (GLP-1) Best weight loss in trials 30.3%22.5%20.7% Trial duration 104 weeks72 weeks72 weeks UK approval Not yetYes (Mounjaro)Yes (Wegovy) Injection frequency Once weeklyOnce weeklyOnce weekly One important caveat: the 30.3% figure comes from a 104-week trial, while the Mounjaro and Wegovy results are from 72-week trials
